La Jolla, CALIFORNIA4 Active Studies

Major Depressive Disorder Clinical Trials in La Jolla, CALIFORNIA

Find 4 actively recruiting major depressive disorder clinical trials in La Jolla, CALIFORNIA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
1,168
Enrolling

Recruiting Major Depressive Disorder Studies in La Jolla

About Major Depressive Disorder Clinical Trials in La Jolla

Major depressive disorder (MDD) is a severe form of depression characterized by persistent sadness, loss of interest, and impaired daily functioning. Treatment-resistant depression (TRD) affects patients who do not respond to standard therapies. Novel treatments like ketamine, psilocybin, and neuromodulation are being studied.

There are currently 4 major depressive disorder clinical trials recruiting participants in La Jolla, CALIFORNIA. These studies are seeking a combined 1,168 participants. Research is being sponsored by COMPASS Pathways, Usona Institute, Cybin IRL Limited and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Major Depressive Disorder Clinical Trials in La Jolla — FAQ

Are there major depressive disorder clinical trials in La Jolla?

Yes, there are 4 major depressive disorder clinical trials currently recruiting in La Jolla, CALIFORNIA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in La Jolla?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the La Jolla research site will contact you about next steps.

Are clinical trials in La Jolla free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many La Jolla studies also compensate for your time and travel.

What major depressive disorder treatments are being tested?

The 4 active trials in La Jolla are testing new therapies including novel drugs, biologics, and treatment approaches for major depressive disorder.

Data updated March 2, 2026 from ClinicalTrials.gov